Notch Inhibitor in Advanced Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The objective of this phase 1 study is to evaluate the safety and tolerability of Notch Inhibitor in participants with advanced cancer. This study includes dose escalation and dose confirmation components.
Epistemonikos ID: 22b6459f7b8c1e8861af9ea5207fff24b95f7f07
First added on: May 05, 2024